Q2 EPS Estimates for BBWI Reduced by Telsey Advisory Group

Bath & Body Works, Inc. (NYSE:BBWI) – Stock analysts at Telsey Advisory Group lowered their Q2 2026 earnings per share estimates for Bath & Body Works in a research note issued to investors on Friday, May 30th. Telsey Advisory Group analyst D. Telsey now expects that the company will post earnings per share of $0.36 for the quarter, down from their previous forecast of $0.42. Telsey Advisory Group currently has a “Outperform” rating and a $38.00 target price on the stock. The consensus estimate for Bath & Body Works’ current full-year earnings is $3.30 per share. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2026 earnings at $2.16 EPS, Q1 2027 earnings at $0.56 EPS, Q2 2027 earnings at $0.45 EPS, Q4 2027 earnings at $2.27 EPS and FY2027 earnings at $3.86 EPS.

BBWI has been the topic of several other reports. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Morgan Stanley cut their target price on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 6th. Barclays cut their target price on Bath & Body Works from $35.00 to $30.00 and set an “equal weight” rating on the stock in a research report on Friday, May 30th. JPMorgan Chase & Co. increased their target price on Bath & Body Works from $41.00 to $43.00 and gave the stock an “overweight” rating in a research report on Monday, May 19th. Finally, Wells Fargo & Company increased their target price on Bath & Body Works from $40.00 to $44.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 14th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $42.00.

Bath & Body Works Trading Up 1.7%

Shares of BBWI opened at $27.18 on Monday. The firm has a market capitalization of $5.79 billion, a P/E ratio of 6.63, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. The stock’s fifty day simple moving average is $29.87 and its 200 day simple moving average is $33.89. Bath & Body Works has a twelve month low of $24.96 and a twelve month high of $49.20.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.38 earnings per share.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. SRS Capital Advisors Inc. increased its position in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares during the last quarter. Northwest Bank & Trust Co increased its position in shares of Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company’s stock worth $533,000 after acquiring an additional 419 shares during the last quarter. Lindbrook Capital LLC increased its position in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after acquiring an additional 431 shares during the last quarter. Cornerstone Investment Partners LLC increased its position in shares of Bath & Body Works by 3.8% during the fourth quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company’s stock worth $475,000 after acquiring an additional 452 shares during the last quarter. Finally, Nicolet Bankshares Inc. increased its position in shares of Bath & Body Works by 2.8% during the fourth quarter. Nicolet Bankshares Inc. now owns 17,232 shares of the company’s stock worth $668,000 after acquiring an additional 463 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works announced that its Board of Directors has initiated a share buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.94%. The ex-dividend date of this dividend is Friday, June 6th. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.